MYLAN 7025 MYLAN 7025 (Loxapine Succinate 25 mg)
Pill with imprint MYLAN 7025 MYLAN 7025 is Green / Brown, Capsule-shape and has been identified as Loxapine Succinate 25 mg. It is supplied by Mylan Pharmaceuticals Inc..
Loxapine is used in the treatment of agitation; agitated state; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 7025 MYLAN 7025
Loxapine Succinate
- Imprint
- MYLAN 7025 MYLAN 7025
- Strength
- 25 mg
- Color
- Green / Brown
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
sodium lauryl sulfate,
magnesium silicate,
ferrosoferric oxide,
FD&C Blue No. 1,
titanium dioxide,
ferric oxide yellow,
D&C Yellow No. 10,
FD&C Green No. 3,
FD&C Blue No. 2,
FD&C Red No. 40,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-7025 | Mylan Pharmaceuticals Inc. |
| 51079-0902 | UDL Laboratories Inc. |
More about loxapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 12 Reviews
- Drug class: miscellaneous antipsychotic agents
- FDA Alerts (2)
Consumer resources
- Patient Information
- Loxapine inhalation
- Loxapine (Advanced Reading)
- Loxapine Inhalation (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.